Emollients & Skin Care
Synthesised from Emollient Therapy, Petrolatum, Mineral Oil, Glycerol, Urea Creams, Ceramides, Linoleic Acid, Oleic Acid, Aqueous Cream, Sodium Lauryl Sulfate, Emollient Bath Additives, BATHE Trial, BEE Trial, BEEP Trial, PreventADALL Trial, Emollient Fire Risk, Bathing Frequency, Soak and Seal, Soap Substitutes, Syndet Cleansers, Wet Wrap Therapy, Barrier Creams, Colloidal Oatmeal and Sunflower Seed Oil (see MOC-emollients-and-skin-care). Corresponds mainly to infranodus cluster 2 (
soak,moisturisers,emollients).
Overview
Emollients (moisturisers) are the foundation of care for Atopic Dermatitis in children aged 1–4. They work in two ways. Occlusives such as Petrolatum and Mineral Oil slow water loss from a leaky stratum corneum. Humectants such as Glycerol and urea draw water into it, much as the skin’s own Natural Moisturising Factor does. NICE says emollients “should always be used, even when the atopic eczema is clear”, and asks for 250–500 g a week of unperfumed product for a child. The Cochrane emollients review (van Zuuren 2017; 77 RCTs) found high-certainty evidence that moisturisers reduce severity, cut flares (RR 0.33) and reduce the amount of Topical Corticosteroids needed. It found “no reliable evidence that one moisturiser is better than another”.
The cluster also covers washing and bathing. Soap, bubble bath and detergents such as Sodium Lauryl Sulfate raise Skin pH and strip barrier lipids, so the routine has three parts: wash with a soap substitute, soak in plain water, then seal with a leave-on emollient (the Soak and Seal method). Three UK NIHR-funded trials changed practice for this age group. The BEE Trial found no difference between lotions, creams, gels and ointments. The BATHE Trial found that Emollient Bath Additives added nothing. The BEEP Trial, together with the Scandinavian PreventADALL Trial, showed that daily emollient from birth does not prevent eczema.
Practical safety runs through the community. Aqueous Cream stings many children because of its SLS content. Dried emollient on fabric is a fire accelerant (Emollient Fire Risk). Plant oils differ in their effect on the barrier depending on their Linoleic Acid to Oleic Acid ratio. The general rule is that the best emollient for a toddler is the one the child tolerates and the parent will actually apply, often.
Key Entities
Emollient Therapy
evidence: strong. Emollients are used in three ways: leave-on moisturisers, soap substitutes and (formerly) bath additives. Lotions suit hairy or weeping skin. Creams suit daytime. Ointments are the most occlusive and are usually preservative-free, but they are not for weeping eczema. Parents are told to “smooth, don’t rub” in the direction of hair growth, ideally 3–4 times a day. They should wait 20–30 minutes between emollient and a steroid, and get a fresh tub after a skin infection because old tubs can become contaminated (NICE CG57). Under-use is common and is linked to more flares.
Emollients treat eczema but do not prevent it. That distinction is the main lesson of the prevention trials below.
Petrolatum
evidence: strong. Petrolatum reduces Transepidermal Water Loss by more than 98% and carries “essentially no risk” of Allergic Contact Dermatitis. That makes it the standard substitute when Lanolin allergy is suspected and the usual chin barrier in Drool Dermatitis. Ghadially et al. (1992) showed that it does more than form a surface film: it moves between corneocytes and speeds barrier recovery. Elias and Wakefield (2011), by contrast, argue that non-physiological lipids do not correct the underlying defect and favour Ceramides formulas. This conflict is unresolved. A Cape Town RCT found petroleum jelly as good as emulsifying ointment, which is why it anchors low-cost regimens in South African Eczema Guidance. Its liquid partner Mineral Oil lowered SCORAD by 38% in a paediatric RCT, although virgin Coconut Oil did better (68%; Evangelista 2014, single trial).
Glycerol and Urea Creams
Glycerol is a humectant found in many standard NHS emollients. In the 2017 Cochrane review it gave a small SCORAD gain (MD −2.20), below the minimal important difference. Head-to-head, it caused less “smarting” than urea, which matters because stinging is a common reason toddlers refuse moisturiser. Urea (2–10% for eczema) has low-quality, single-trial evidence of benefit and more adverse events than control (RR 1.65). It often stings raw toddler skin. Ceramides creams rest on a plausible lipid-replacement rationale and sting less than urea. However, the cleanest paediatric RCT (Gupta 2023, n=53) found them no better than a paraffin moisturiser, and a 2023 meta-analysis found only a tiny SCORAD difference.
BEE Trial
evidence: strong. Ridd et al. (2022) randomised 550 children aged 6 months to 12 years (median age 4) to lotion, cream, gel or ointment. POEM differences were all under half a point (p = 0.77). Stinging was least frequent with ointments (9% vs 17–20%). For a 1–4-year-old there is no “best” type. Preference and tolerability decide, which supports trying several products and prescribing the cheapest acceptable one.
Emollient Bath Additives and the BATHE Trial
BATHE (Santer, BMJ 2018) randomised 483 children aged 1–11 in 96 GP practices. Adding bath oil to usual care changed POEM by only 0.41 points, far below the 3-point minimal clinically important difference, with no benefit on any secondary outcome. The finding saved the NHS more than £23 million a year in prescriptions. NHS England stopped routine prescribing in 2019, and NICE CG57 advised in 2023 not to offer bath additives to under-12s. BATHE could not rule out a small benefit in under-5s who bathe very often, but judged any such effect too small to matter. Oily bath water is also slippery for a wriggling toddler.
BEEP Trial and PreventADALL Trial
BEEP randomised 1,394 high-risk UK newborns to daily emollient for a year. Eczema at age 2 was 23% vs 25% (aRR 0.95), with no late benefit at 5 years. Skin infections increased (IRR 1.55), and food allergy at age 2 showed a possible, non-significant rise (7.5% vs 5.1%). PreventADALL (2,397 general-population Nordic infants) also found that emollients did not prevent eczema. Its risk difference of 3.1% (CI −0.3 to 6.5) is reported by one 2024 review as a “mild increase”, which is an unresolved conflict. Its separate food arm showed that early allergenic foods reduced Food Allergy. Both trials fed the 2022 Cochrane conclusion that infant emollients “probably” do not prevent eczema.
Aqueous Cream and Sodium Lauryl Sulfate
Aqueous Cream BP contains about 1% SLS. Applied for 4 weeks, it thinned the stratum corneum by 12% and raised TEWL by 20% in healthy volunteers (Tsang & Guy 2010). In a clinic audit it caused immediate stinging in 56% of child exposures, against 18% for other emollients. The MHRA (2013) warned against leave-on use. NICE and the MHRA still allow it as a wash, but dermatology nurse specialists and the National Eczema Society advise against it even for washing. This conflict is unresolved. South African public clinics still issue it, but limit it to washing only.
Soap Substitutes and Syndet Cleansers
Alkaline soap can raise skin pH by about 3 units for 90 minutes. UK guidance prefers a teaspoon of the child’s leave-on emollient used as a wash. The American Academy of Dermatology accepts limited use of neutral-to-low-pH, fragrance-free syndets. Labels are unreliable: in a test of 250 cleansers, 84.9% of liquid syndets were acidic, but none of the 14 syndet bars was, and few products stated their pH. Liquids are therefore the safer choice.
Fragrance on broken skin
Perfumed washes and “unscented” products can cause or reveal Fragrance Allergy on inflamed toddler skin. Choose products labelled fragrance-free.
Bathing Frequency and Soak and Seal
Two small RCTs disagree. Koutroulis 2014 (n=28) found no difference between daily and twice-weekly baths. Cardona 2020 (n=42, moderate–severe eczema) found that twice-daily 15–20 minute soaks followed by immediate occlusive moisturiser lowered SCORAD by 21.2 points more than twice-weekly short baths. The key element is timing: apply emollient within about 3 minutes of leaving the bath, before evaporation dries the skin. Recommended soak times vary between 5–10 minutes (NEA), 10–15 minutes (AAD) and 15–20 minutes (Cardona). evidence: moderate.
Wet Wrap Therapy
A damp cotton layer and a dry layer are placed over emollient or steroid after a soak, for severe flares or itch that is disrupting sleep. Uncontrolled programmes report large gains (a 71% symptom reduction; Nicol 2014). The only meta-analysis (González-López 2017; six small RCTs) rated the evidence that wet wraps beat Topical Corticosteroids alone as low quality. Risks include Folliculitis from overuse and increased steroid absorption under occlusion, so wraps over steroid should be clinician-guided. evidence: weak.
Emollient Fire Risk
Emollient on skin is not flammable, but dried residue on fabric acts as an accelerant. In 2018 the MHRA extended its warning from products with more than 50% paraffin to all paraffin-containing emollients, and said the risk “cannot be excluded” for paraffin-free ones. It cited 11 deaths in which paraffin-based emollients probably made a fire faster and more intense. High-temperature washing reduces build-up but does not remove it. For toddlers, the items at risk are sleepsuits, cot sheets and wet-wrap layers.
Emollient-soaked fabric burns
Keep children in emollient-treated clothing and bedding away from open flames, heaters and cigarettes. Washing does not fully remove residue.
Other members
Barrier Creams (petrolatum, zinc oxide, dimeticone) protect the wet, friction-prone zones affected by Nappy Rash and drool rash. They do not treat inflammation, and zinc and castor oil ointment may contain arachis (peanut) oil. Among plant oils, Sunflower Seed Oil is linoleic-rich and spared the adult barrier (Danby 2013), whereas oleic-rich Olive Oil damaged it. In newborns, however, both oils delayed lipid-lamellae maturation (Cooke 2016), which is unresolved. Colloidal Oatmeal is an FDA-recognised skin protectant and was non-inferior to a barrier cream in 90 children, but the Cochrane review found more adverse events with oat products, and oat proteins can sensitise infants with AD.
Nut-based oils
Nut-derived oils on inflamed skin may sensitise a young child to that nut (see Peanut Oil Sensitisation). Prefer a licensed emollient or refined sunflower oil.
Connections Within This Community
Emollient Therapy [part-of] Soak and Seal Petrolatum [part-of] Emollient Therapy Mineral Oil [part-of] Emollient Therapy Glycerol [part-of] Emollient Therapy Glycerol [relates] Urea Creams Ceramides [contradicts] Petrolatum BEE Trial [supports] Emollient Therapy BATHE Trial [opposes] Emollient Bath Additives BEEP Trial [contradicts] Emollient Therapy PreventADALL Trial [supports] BEEP Trial Sodium Lauryl Sulfate [part-of] Aqueous Cream Aqueous Cream [opposes] Soap Substitutes Syndet Cleansers [part-of] Soap Substitutes Soak and Seal [part-of] Wet Wrap Therapy Bathing Frequency [relates] Soak and Seal Emollient Fire Risk [relates] Wet Wrap Therapy Linoleic Acid [contradicts] Oleic Acid Sunflower Seed Oil [relates] Linoleic Acid
Bridges to Other Communities
- MOC-disease-and-mechanisms: emollients target Skin Barrier Dysfunction, Transepidermal Water Loss, Skin pH and Natural Moisturising Factor loss, especially where Filaggrin is deficient. The infranodus bridge concept
dysfunctionlinks the two clusters. - MOC-prescription-anti-inflammatory-therapies: emollients lower steroid needs. Soak and Seal and Wet Wrap Therapy are the vehicles for Topical Corticosteroids, and Stepped Care Approach keeps emollients at every step.
- MOC-home-and-herbal-remedies: plant oils (Coconut Oil, Olive Oil, Sunflower Seed Oil, Shea Butter) and Colloidal Oatmeal sit on the border between licensed emollients and Track A remedies. The infranodus bridge candidate
soaklinks bathing advice to herbal bath practices. - MOC-triggers-and-allergy: soap, Sodium Lauryl Sulfate, Hard Water and fragrance are irritant triggers. Lanolin and nut oils are contact or food sensitisers, and the PreventADALL Trial food arm links to Food Allergy prevention.
- MOC-infection: BEEP’s excess skin infections, contaminated emollient tubs and Bleach Baths connect skin care to Staphylococcus aureus.
- MOC-evidence-base-and-guidance: Cochrane, NICE CG57, MHRA and NHS England deprescribing turned these trials into policy.
Open Questions
- emollient-therapy-questions
- emollient-therapy-conflicts
- emollient-chemistry-questions
- emollient-chemistry-conflicts
- emollient-ingredients-questions
- emollient-ingredients-conflicts
- emollient-practicalities-questions
- emollient-practicalities-conflicts
- water-therapies-questions
- water-therapies-conflicts
- moisturisation-physiology-questions
- moisturisation-physiology-conflicts
- Gap-derived (cochrane ↔ definition): Do any Cochrane-pooled emollient trials report results separately for 1–4-year-olds? Is there a toddler-specific threshold for how many grams per week, or how many applications per day, gives a measurable flare reduction?
- Gap-derived (definition ↔ nice): Should NICE’s ban on bath additives be extended to a position on soak duration and frequency, given the Cardona 2020 soak-and-seal result in moderate-to-severe disease?